Silodosin cải thiện các hậu quả chức năng của tắc nghẽn đường tiết niệu dưới do phì đại tuyến tiền liệt lành tính, một nghiên cứu chứng minh khái niệm trên chuột tự sinh huyết áp cao được bổ sung testosterone
Tóm tắt
Từ khóa
#silodosin #phì đại tuyến tiền liệt lành tính #chuột tự sinh huyết áp cao #urodynamic #triệu chứng đường tiết niệu dướiTài liệu tham khảo
Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2011;60(4):809–25.
Gravas S, Cornu JN, Gacci C, et al. EAU guidelines on Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign prostatic obstruction (BPO). Edn. presented at the EAU Annual congress Barcelona. Arnhem: EAU Guidelines Office; 2019.
Michel MC, Vrydag W. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol. 2006;147(Suppl 2):S88–119.
Creta M, Bottone F, Sannino S, Maisto E, Franco M, Mangiapia F, et al. Effects of alpha1-blockers on urodynamic parameters of bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: a review. Minerva Urol Nefrol. 2015.
Fusco F, Palmieri A, Ficarra V, Giannarini G, Novara G, Longo N, et al. alpha1-blockers improve benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review and meta-analysis of urodynamic studies. Eur Urol. 2016;69(6):1091–101.
Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernandez FE. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol. 2011;59(3):342–52.
Michel MC, Schafers RF, Goepel M. Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation? BJU Int. 2000;86(Suppl 2):23–8.
Oudot A, Oger S, Behr-Roussel D, Caisey S, Bernabe J, Alexandre L, et al. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat. BJU Int. 2012;110(9):1352–8.
Kessler TM, Gerber R, Burkhard FC, Studer UE, Danuser H. Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol. 2006;175:2170–3.
Oelke M, Hofner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol. 2007;52:827–34.
Maggi CA, Manzini S, Giuliani S, Meli A. Infravesical outflow obstruction in rats: a comparison of two models. Gen Pharmacol. 1989;20(3):345–9.
Kawabe K, Yoshida M, Homma Y. Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int. 2006;98(5):1019–24.
Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol. 2009;181(6):2634–40.
Jin LH, Andersson KE, Kwon YH, Park CS, Yoon SM, Lee T. Substantial detrusor overactivity in conscious spontaneously hypertensive rats with hyperactive behaviour. Scand J Urol Nephrol. 2009;43(1):3–7.
Patra PB, Thorneloe KS. Enhanced sensitivity to afferent stimulation and impact of overactive bladder therapies in the conscious, spontaneously hypertensive rat. J Pharmacol Exp Ther. 2011;338(1):392–9.
Inoue S, Saito M, Tsounapi P, Dimitriadis F, Ohmasa F, Kinoshita Y, et al. Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat. BJU Int. 2012;110(2 Pt 2):E118–24.
Aizawa N, Watanabe D, Fukuhara H, Fujimura T, Kume H, Homma Y, et al. Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction. Neurourol Urodyn. 2018.
Goi Y, Tomiyama Y, Yokoyama A, Tatemichi S, Maruyama K, Kobayashi M, et al. Effect of silodosin, a selective alpha(1A)-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction. Eur J Pharmacol. 2015;764:489–96.
Persson K, Pandita RK, Spitsbergen JM, Steers WD, Tuttle JB, Andersson KE. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Phys. 1998;275(4 Pt 2):R1366–73.
Yazaki J, Aikawa K, Shishido K, Yanagida T, Nomiya M, Ishibashi K, et al. Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction. Neurourol Urodyn. 2011;30(3):461–7.
Seki S, Erickson KA, Seki M, Nishizawa O, Igawa Y, Ogawa T, et al. Elimination of rat spinal neurons expressing neurokinin 1 receptors reduces bladder overactivity and spinal c-fos expression induced by bladder irritation. Am J Physiol Renal Physiol. 2005;288(3):F466–73.
Fusco F, Creta M, De NC, Iacovelli V, Mangiapia F, Li MV, et al. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018;18(1):15.
Saito M, Shimizu S, Ohmasa F, Oikawa R, Tsounapi P, Dimitriadis F, et al. Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat. Neurourol Urodyn. 2013;32(4):393–8.
Masuda H, Kihara K, Saito K, Matsuoka Y, Yoshida S, Chancellor MB, et al. Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU Int. 2008;101(6):775–80.
Goi Y, Tomiyama Y, Maruyama I, Tatemichi S, Maruyama K, Kobayashi M, et al. Silodosin, an alpha(1A)-Adrenoceptor antagonist, may ameliorate ischemia-induced bladder denervation and detrusor dysfunction by improving bladder blood flow. Pharmacology. 2016;97(3–4):161–70.
Uvin P, Everaerts W, Pinto S, Alpízar YA, Boudes M, Gevaert T, et al. The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation. J Vis Exp. 2012;66:e3869. https://doi.org/10.3791/3869.
Andersson KE, Soler R, Füllhase C. Rodent models for urodynamic investigation. Neurourol Urodynam. 2011;30:636–46.